Axsome Therapeutics (AXSM) revenue

Revenue · fiscal 2025
$638.50M

Axsome Therapeutics (AXSM) reported revenue of $638.50M in fiscal 2025 (the year ended December 31, 2025). That is 65.5% higher than the $385.69M of fiscal 2024. Figures as of 18 Nov 2026, 06:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$638.50M
Change on fiscal 2024
+65.5%
Highest on record
$638.50Mfiscal 2025
Lowest on record
$50.04Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Axsome Therapeutics revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $638.50M in fiscal 2025 and the lowest $50.04M in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Axsome Therapeutics revenue, year by year

Axsome Therapeutics (AXSM) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$638.50M 65.5% up
2024$385.69M 42.5% up
2023$270.60M 440.8% up
2022$50.04M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Axsome Therapeutics and comparable companies
CompanyRevenueFiscal year
Axsome Therapeutics AXSM$638.50M2025
Chemed CHE$2.53B2025
Arrowhead Pharmaceuticals ARWR$450.82M2026
MSA Safety MSA$1.87B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AXSM

Axsome Therapeutics, figure by figure

Axsome Therapeutics (AXSM) overview: price, valuation and scorecardAll health care companies by market value

Axsome Therapeutics revenue: questions and answers

What is Axsome Therapeutics's revenue?

Axsome Therapeutics (AXSM) reported revenue of $638.50M in fiscal 2025 (the year ended December 31, 2025). That is 65.5% higher than the $385.69M of fiscal 2024.

What are the highest and lowest revenue figures on record for Axsome Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $638.50M in fiscal 2025 and the lowest $50.04M in fiscal 2022.

How is Axsome Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Axsome Therapeutics (AXSM) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AXSM/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.